Anuh Pharma Limited (NSE:ANUHPHR)

Market Cap	8.28B -5.7%
Revenue (ttm)	7.78B +6.5%
Net Income	477.70M +23.4%
EPS	4.76 +23.3%
Shares Out	n/a
PE Ratio	17.20
Forward PE	n/a
Dividend	1.50 (1.83%)
Ex-Dividend Date	Aug 5, 2026

Volume	59,604
Open	83.92
Previous Close	82.16
Day's Range	81.00 - 83.94
52-Week Range	67.00 - 99.50
Beta	0.48
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Anuh Pharma

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-hypertension, expectorant, anti-diabetics, anti-bacterial, anti-gout, anti asthmatics, quinolones, anti biotic, anti platelet, anti-histamines, and intermediates; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, and anti-mitotic. The company also develops products, such as anticoagulant, antagonist, anti convulsants, anty-u...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 323
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ANUHPHR

Financial Performance

In fiscal year 2026, Anuh Pharma's revenue was 7.72 billion, an increase of 16.65% compared to the previous year's 6.62 billion. Earnings were 410.46 million, a decrease of -13.32%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error